{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:24:42Z","timestamp":1772526282420,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11427-021-2031-7","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T16:02:27Z","timestamp":1640707347000},"page":"1181-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo"],"prefix":"10.1007","volume":"65","author":[{"given":"Haoran","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongtian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"2031_CR1","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.3390\/ijms21103544","volume":"21","author":"M Abu-Farha","year":"2020","unstructured":"Abu-Farha, M., Thanaraj, T.A., Qaddoumi, M.G., Hashem, A., Abubaker, J., and Al-Mulla, F. (2020). The role of lipid metabolism in COVID-19 virus infection and as a drug target. Int J Mol Sci 21, 3544.","journal-title":"Int J Mol Sci"},{"key":"2031_CR2","doi-asserted-by":"publisher","first-page":"e04502","DOI":"10.1016\/j.heliyon.2020.e04502","volume":"6","author":"J Ahmad","year":"2020","unstructured":"Ahmad, J., Ikram, S., Ahmad, F., Rehman, I.U., and Mushtaq, M. (2020). SARS-CoV-2 RNA dependent RNA polymerase (RdRp)\u2014a drug repurposing study. Heliyon 6, e04502.","journal-title":"Heliyon"},{"key":"2031_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.antiviral.2016.11.015","volume":"137","author":"A Balasubramanian","year":"2017","unstructured":"Balasubramanian, A., Teramoto, T., Kulkarni, A.A., Bhattacharjee, A.K., and Padmanabhan, R. (2017). Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus. Antiviral Res 137, 141\u2013150.","journal-title":"Antiviral Res"},{"key":"2031_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/bib\/bbaa379","volume":"22","author":"B Berber","year":"2021","unstructured":"Berber, B., and Doluca, O. (2021). A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin-dopamine receptors. Brief Bioinform 22, 1023\u20131037.","journal-title":"Brief Bioinform"},{"key":"2031_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","volume":"182","author":"M Bouhaddou","year":"2020","unstructured":"Bouhaddou, M., Memon, D., Meyer, B., White, K.M., Rezelj, V.V., Correa Marrero, M., Polacco, B.J., Melnyk, J.E., Ulferts, S., Kaake, R.M., et al. (2020). The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182, 685\u2013712.e19.","journal-title":"Cell"},{"key":"2031_CR6","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.xcrm.2020.100142","volume":"1","author":"A Carpinteiro","year":"2020","unstructured":"Carpinteiro, A., Edwards, M.J., Hoffmann, M., Kochs, G., Gripp, B., Weigang, S., Adams, C., Carpinteiro, E., Gulbins, A., Keitsch, S., et al. (2020). Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells. Cell Rep Med 1, 100142.","journal-title":"Cell Rep Med"},{"key":"2031_CR7","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1038\/s41467-021-24156-y","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Lear, T.B., Evankovich, J.W., Larsen, M.B., Lin, B., Alfaras, I., Kennerdell, J.R., Salminen, L., Camarco, D.P., Lockwood, K.C., et al. (2021). A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry. Nat Commun 12, 3907.","journal-title":"Nat Commun"},{"key":"2031_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.antiviral.2014.09.007","volume":"111","author":"YY Cheung","year":"2014","unstructured":"Cheung, Y.Y., Chen, K.C., Chen, H., Seng, E.K., and Chu, J.J.H. (2014). Antiviral activity of lanatoside C against dengue virus infection. Antiviral Res 111, 93\u201399.","journal-title":"Antiviral Res"},{"key":"2031_CR9","doi-asserted-by":"publisher","first-page":"108959","DOI":"10.1016\/j.celrep.2021.108959","volume":"35","author":"M Dittmar","year":"2021","unstructured":"Dittmar, M., Lee, J.S., Whig, K., Segrist, E., Li, M., Kamalia, B., Castellana, L., Ayyanathan, K., Cardenas-Diaz, F.L., Morrisey, E.E., et al. (2021). Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-CoV-2. Cell Rep 35, 108959.","journal-title":"Cell Rep"},{"key":"2031_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1126\/science.abg5827","volume":"373","author":"N Drayman","year":"2021","unstructured":"Drayman, N., DeMarco, J.K., Jones, K.A., Azizi, S.A., Froggatt, H.M., Tan, K., Maltseva, N.I., Chen, S., Nicolaescu, V., Dvorkin, S., et al. (2021). Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science 373, 931\u2013936.","journal-title":"Science"},{"key":"2031_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/v13050873","volume":"13","author":"RJ Eberle","year":"2021","unstructured":"Eberle, R.J., Olivier, D.S., Amaral, M.S., Gering, I., Willbold, D., Arni, R. K., and Coronado, M.A. (2021). The repurposed drugs suramin and quinacrine cooperatively inhibit SARS-CoV-2 3CLproin vitro. Viruses 13, 873.","journal-title":"Viruses"},{"key":"2031_CR12","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.3390\/ijms21165807","volume":"21","author":"K Farsalinos","year":"2020","unstructured":"Farsalinos, K., Eliopoulos, E., Leonidas, D.D., Papadopoulos, G.E., Tzartos, S., and Poulas, K. (2020). Nicotinic cholinergic system and COVID-19: in silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting implications. Int J Mol Sci 21, 5807.","journal-title":"Int J Mol Sci"},{"key":"2031_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/microorganisms9030566","volume":"9","author":"CL Finch","year":"2021","unstructured":"Finch, C.L., Dyall, J., Xu, S., Nelson, E.A., Postnikova, E., Liang, J.Y., Zhou, H., DeWald, L.E., Thomas, C.J., Wang, A., et al. (2021). Formulation, stability, pharmacokinetic, and modeling studies for tests of synergistic combinations of orally available approved drugs against ebola virus in vivo. Microorganisms 9, 566.","journal-title":"Microorganisms"},{"key":"2031_CR14","doi-asserted-by":"publisher","first-page":"e1009705","DOI":"10.1371\/journal.ppat.1009705","volume":"17","author":"ME Francis","year":"2021","unstructured":"Francis, M.E., Goncin, U., Kroeker, A., Swan, C., Ralph, R., Lu, Y., Etzioni, A.L., Falzarano, D., Gerdts, V., Machtaler, S., et al. (2021). SARS-CoV-2 infection in the syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney. PLoS Pathog 17, e1009705.","journal-title":"PLoS Pathog"},{"key":"2031_CR15","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1021\/acs.jpclett.0c01579","volume":"11","author":"K Gao","year":"2020","unstructured":"Gao, K., Nguyen, D.D., Chen, J., Wang, R., and Wei, G.W. (2020a). Repositioning of 8565 existing drugs for COVID-19. J Phys Chem Lett 11, 5373\u20135382.","journal-title":"J Phys Chem Lett"},{"key":"2031_CR16","doi-asserted-by":"publisher","first-page":"106026","DOI":"10.1016\/j.rmed.2020.106026","volume":"169","author":"M Gao","year":"2020","unstructured":"Gao, M., Yang, L., Chen, X., Deng, Y., Yang, S., Xu, H., Chen, Z., and Gao, X. (2020b). A study on infectivity of asymptomatic SARS-CoV-2 carriers. Respir Med 169, 106026.","journal-title":"Respir Med"},{"key":"2031_CR17","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/jac\/dku091","volume":"69","author":"G Gehring","year":"2014","unstructured":"Gehring, G., Rohrmann, K., Atenchong, N., Mittler, E., Becker, S., Dahlmann, F., P\u00d6hlmann, S., Vondran, F.W.R., David, S., Manns, M.P., et al. (2014). The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother 69, 2123\u20132131.","journal-title":"J Antimicrob Chemother"},{"key":"2031_CR18","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D.K., Kubin, C., Barr, R.G., et al. (2020). Observational study of hydroxychloroquine in hospitalized patients with COVID-19. N Engl J Med 382, 2411\u20132418.","journal-title":"N Engl J Med"},{"key":"2031_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/ph14040332","volume":"14","author":"T Ginex","year":"2021","unstructured":"Ginex, T., Garaigorta, U., Ramirez, D., Castro, V., Nozal, V., Maestro, I., Garc\u00eda-C\u00e1rceles, J., Campillo, N.E., Martinez, A., Gastaminza, P., et al. (2021). Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico\/in vitro screening methods. Pharmaceuticals 14, 332.","journal-title":"Pharmaceuticals"},{"key":"2031_CR20","unstructured":"Global report investigating novel coronavirus haplotypes. https:\/\/cov-lineages.org\/global_report.html."},{"key":"2031_CR21","doi-asserted-by":"publisher","first-page":"35631","DOI":"10.1074\/jbc.M112.382341","volume":"287","author":"M Guan","year":"2012","unstructured":"Guan, M., Wang, W., Liu, X., Tong, Y., Liu, Y., Ren, H., Zhu, S., Dubuisson, J., Baumert, T.F., Zhu, Y., et al. (2012). Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion. J Biol Chem 287, 35631\u201335645.","journal-title":"J Biol Chem"},{"key":"2031_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","volume":"589","author":"Y Han","year":"2021","unstructured":"Han, Y., Duan, X., Yang, L., Nilsson-Payant, B.E., Wang, P., Duan, F., Tang, X., Yaron, T.M., Zhang, T., Uhl, S., et al. (2021). Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature 589, 270\u2013275.","journal-title":"Nature"},{"key":"2031_CR23","doi-asserted-by":"crossref","unstructured":"Herring, S., Oda, J.M., Wagoner, J., Kirchmeier, D., O\u2019Connor, A., Nelson, E.A., Huang, Q., Liang, Y., DeWald, L.E., Johansen, L.M., et al. (2021). Inhibition of arenaviruses by combinations of orally available approved drugs. Antimicrob Agents Chemother 65.","DOI":"10.1128\/AAC.00653-21"},{"key":"2031_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/v12060642","volume":"12","author":"A Ianevski","year":"2020","unstructured":"Ianevski, A., Yao, R., Fenstad, M.H., Biza, S., Zusinaite, E., Reisberg, T., Lysvand, H., L\u00f8seth, K., Landsem, V.M., Malmring, J.F., et al. (2020). Potential antiviral options against SARS-CoV-2 infection. Viruses 12, 642.","journal-title":"Viruses"},{"key":"2031_CR25","doi-asserted-by":"publisher","first-page":"e1009439","DOI":"10.1371\/journal.ppat.1009439","volume":"17","author":"X Ju","year":"2021","unstructured":"Ju, X., Zhu, Y., Wang, Y., Li, J., Zhang, J., Gong, M., Ren, W., Li, S., Zhong, J., Zhang, L., et al. (2021). A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS Pathog 17, e1009439.","journal-title":"PLoS Pathog"},{"key":"2031_CR26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s11427-020-1871-4","volume":"64","author":"Q Li","year":"2021","unstructured":"Li, Q., Cui, C., Xu, F., Zhao, J., Li, N., Li, H., Wang, T., Zhang, H., Liu, N., Wei, Y., et al. (2021). Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19. Sci China Life Sci 64, 660\u2013663.","journal-title":"Sci China Life Sci"},{"key":"2031_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ijid.2020.06.036","volume":"99","author":"Z Liu","year":"2020","unstructured":"Liu, Z., Chu, R., Gong, L., Su, B., and Wu, J. (2020). The assessment of transmission efficiency and latent infection period in asymptomatic carriers of SARS-CoV-2 infection. Int J Infect Dis 99, 325\u2013327.","journal-title":"Int J Infect Dis"},{"key":"2031_CR28","doi-asserted-by":"publisher","first-page":"n2422","DOI":"10.1136\/bmj.n2422","volume":"375","author":"E Mahase","year":"2021","unstructured":"Mahase, E. (2021). COVID-19: molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports. BMJ 375, n2422.","journal-title":"BMJ"},{"key":"2031_CR29","doi-asserted-by":"publisher","first-page":"e2105815118","DOI":"10.1073\/pnas.2105815118","volume":"118","author":"C Mirabelli","year":"2021","unstructured":"Mirabelli, C., Wotring, J.W., Zhang, C.J., McCarty, S.M., Fursmidt, R., Pretto, C.D., Qiao, Y., Zhang, Y., Frum, T., Kadambi, N.S., et al. (2021). Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc Natl Acad Sci USA 118, e2105815118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2031_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s10637-017-0470-z","volume":"35","author":"M Mori","year":"2017","unstructured":"Mori, M., Kaneko, N., Ueno, Y., Yamada, M., Tanaka, R., Saito, R., Shimada, I., Mori, K., and Kuromitsu, S. (2017). Gilteritinib, a FLT3\/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia. Invest New Drugs 35, 556\u2013565.","journal-title":"Invest New Drugs"},{"key":"2031_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/950658","volume":"2012","author":"C Naujokat","year":"2012","unstructured":"Naujokat, C., and Steinhart, R. (2012). Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol 2012, 1\u201317.","journal-title":"J Biomed Biotechnol"},{"key":"2031_CR32","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1073\/pnas.81.15.4955","volume":"81","author":"GR Nemerow","year":"1984","unstructured":"Nemerow, G.R., and Cooper, N.R. (1984). Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists. Proc Natl Acad Sci U S A 81, 4955\u20134959.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2031_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0166-3542(91)90032-M","volume":"15","author":"H Ochiai","year":"1991","unstructured":"Ochiai, H., Kurokawa, M., and Niwayama, S. (1991). Influence of trifluoperazine on the late stage of influenza virus infection in MDCK cells. Antiviral Res 15, 149\u2013160.","journal-title":"Antiviral Res"},{"key":"2031_CR34","doi-asserted-by":"publisher","first-page":"173553","DOI":"10.1016\/j.ejphar.2020.173553","volume":"887","author":"M Otr\u0119ba","year":"2020","unstructured":"Otr\u0119ba, M., Ko\u015bmider, L., and Rzepecka-Stojko, A. (2020). Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review. Eur J Pharmacol 887, 173553.","journal-title":"Eur J Pharmacol"},{"key":"2031_CR35","doi-asserted-by":"publisher","first-page":"117883","DOI":"10.1016\/j.lfs.2020.117883","volume":"256","author":"A Pandey","year":"2020","unstructured":"Pandey, A., Nikam, A.N., Shreya, A.B., Mutalik, S.P., Gopalan, D., Kulkarni, S., Padya, B.S., Fernandes, G., Mutalik, S., and Prassl, R. (2020). Potential therapeutic targets for combating SARS-CoV-2: drug repurposing, clinical trials and recent advancements. Life Sci 256, 117883.","journal-title":"Life Sci"},{"key":"2031_CR36","doi-asserted-by":"publisher","unstructured":"Patten, J.J., Keiser, P.T., Gysi, D., Menichetti, G., Mori, H., Donahue, C.J., Gan, X., Do Valle, I., Geoghegan-Barek, K., Anantpadma, M. et al. (2021). Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors in vitro and in vivo. bioRxiv doi: https:\/\/doi.org\/10.1101\/2021.04.20.440626.","DOI":"10.1101\/2021.04.20.440626"},{"key":"2031_CR37","first-page":"365","volume":"41","author":"HR Peng","year":"2020","unstructured":"Peng, H.R., Li, C.Z., Tang, H.L., Xue, J.Y., Chen, Z.H., Liang, X.S., Zhu, Y.M., Xia, B.H., Zhu, Y.J., Wu, J.J. et al. (2020). Isolation and identification of two strains of severe acute respiratory syndrome coronavirus 2 from coronavirus disease 2019 patients in Shanghai (in Chinese). Acad J Sec Mil Med Univ 41, 365\u2013370.","journal-title":"Acad J Sec Mil Med Univ"},{"key":"2031_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","volume":"592","author":"JA Plante","year":"2021","unstructured":"Plante, J.A., Liu, Y., Liu, J., Xia, H., Johnson, B.A., Lokugamage, K.G., Zhang, X., Muruato, A.E., Zou, J., Fontes-Garfias, C.R., et al. (2021). Spike mutation d614g alters SARS-CoV-2 fitness. Nature 592, 116\u2013121.","journal-title":"Nature"},{"key":"2031_CR39","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1021\/acsomega.0c05996","volume":"6","author":"AC Puhl","year":"2021","unstructured":"Puhl, A.C., Fritch, E.J., Lane, T.R., Tse, L.V., Yount, B.L., Sacramento, C. Q., Fintelman-Rodrigues, N., Tavella, T.A., Maranh\u00e3o Costa, F.T., Weston, S., et al. (2021). Repurposing the Ebola and Marburg virus inhibitors tilorone, quinacrine, and pyronaridine: In vitro activity against SARS-CoV-2 and potential mechanisms. ACS Omega 6, 7454\u20137468.","journal-title":"ACS Omega"},{"key":"2031_CR40","doi-asserted-by":"publisher","first-page":"taab005","DOI":"10.1093\/jtm\/taab005","volume":"28","author":"S Rakedzon","year":"2021","unstructured":"Rakedzon, S., Neuberger, A., Domb, A.J., Petersiel, N., and Schwartz, E. (2021). From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2? J Travel Med 28, taab005.","journal-title":"J Travel Med"},{"key":"2031_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","volume":"586","author":"L Riva","year":"2020","unstructured":"Riva, L., Yuan, S., Yin, X., Martin-Sancho, L., Matsunaga, N., Pache, L., Burgstaller-Muehlbacher, S., De Jesus, P.D., Teriete, P., Hull, M.V., et al. (2020). Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 586, 113\u2013119.","journal-title":"Nature"},{"key":"2031_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2013.52","volume":"2","author":"G Sharma","year":"2013","unstructured":"Sharma, G., Champalal Sharma, D., Hwei Fen, L., Pathak, M., Bethur, N., Pendharkar, V., Peiris, M., and Altmeyer, R. (2013). Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor. Emerg Microbes Infect 2, 1\u20139.","journal-title":"Emerg Microbes Infect"},{"key":"2031_CR43","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1182\/blood.V128.22.2830.2830","volume":"128","author":"Y Ueno","year":"2016","unstructured":"Ueno, Y., Mori, M., Kamiyama, Y., Kaneko, N., Isshiki, E., and Takeuchi, M. (2016). Gilteritinib (ASP2215), a novel FLT3\/AXL inhibitor: Preclinical evaluation in combination with azacitidine in acute myeloid leukemia. Blood 128, 2830.","journal-title":"Blood"},{"key":"2031_CR44","doi-asserted-by":"publisher","first-page":"11234","DOI":"10.1038\/s41598-021-90701-w","volume":"11","author":"ER Vagapova","year":"2021","unstructured":"Vagapova, E.R., Lebedev, T.D., and Prassolov, V.S. (2021). Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Sci Rep 11, 11234.","journal-title":"Sci Rep"},{"key":"2031_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cell.2020.11.020","volume":"184","author":"E Volz","year":"2021","unstructured":"Volz, E., Hill, V., McCrone, J.T., Price, A., Jorgensen, D., O\u2019Toole, \u00c1., Southgate, J., Johnson, R., Jackson, B., Nascimento, F.F., et al. (2021). Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell 184, 64\u201375.e11.","journal-title":"Cell"},{"key":"2031_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., and Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30, 269\u2013271.","journal-title":"Cell Res"},{"key":"2031_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang, S., Qiu, Z., Hou, Y., Deng, X., Xu, W., Zheng, T., Wu, P., Xie, S., Bian, W., Zhang, C., et al. (2021). AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res 31, 126\u2013140.","journal-title":"Cell Res"},{"key":"2031_CR48","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1111\/bjh.16962","volume":"190","author":"AJ Wilson","year":"2020","unstructured":"Wilson, A.J., Troy-Barnes, E., Subhan, M., Clark, F., Gupta, R., Fielding, A.K., Kottaridis, P., Mansour, M.R., O\u2019Nions, J., Payne, E., et al. (2020). Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19. Br J Haematol 190, e189\u2013e190.","journal-title":"Br J Haematol"},{"key":"2031_CR49","doi-asserted-by":"publisher","first-page":"586572","DOI":"10.3389\/fimmu.2020.586572","volume":"11","author":"X Xiao","year":"2020","unstructured":"Xiao, X., Wang, C., Chang, D., Wang, Y., Dong, X., Jiao, T., Zhao, Z., Ren, L., Dela Cruz, C.S., Sharma, L., et al. (2020). Identification of potent and safe antiviral therapeutic candidates against SARS-CoV-2. Front Immunol 11, 586572.","journal-title":"Front Immunol"},{"key":"2031_CR50","doi-asserted-by":"crossref","unstructured":"Xing, J., Paithankar, S., Liu, K., Uhl, K., Li, X., Ko, M., Kim, S., Haskins, J., and Chen, B. (2021). Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals. Brief Bioinform 22.","DOI":"10.1093\/bib\/bbab249"},{"key":"2031_CR51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bj.2020.05.003","volume":"43","author":"CW Yang","year":"2020","unstructured":"Yang, C.W., Peng, T.T., Hsu, H.Y., Lee, Y.Z., Wu, S.H., Lin, W.H., Ke, Y. Y., Hsu, T.A., Yeh, T.K., Huang, W.Z., et al. (2020). Repurposing old drugs as antiviral agents for coronaviruses. Biomed J 43, 368\u2013374.","journal-title":"Biomed J"},{"key":"2031_CR52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11427-020-1782-1","volume":"64","author":"B Yu","year":"2021","unstructured":"Yu, B., Li, C., Chen, P., Li, J., Jiang, H., and Wang, D.W. (2021). Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs. Sci China Life Sci 64, 330\u2013333.","journal-title":"Sci China Life Sci"},{"key":"2031_CR53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/jiab247","volume":"224","author":"S Zhou","year":"2021","unstructured":"Zhou, S., Hill, C.S., Sarkar, S., Tse, L.V., Woodburn, B.M.D., Schinazi, R. F., Sheahan, T.P., Baric, R.S., Heise, M.T., and Swanstrom, R. (2021). p-d-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells. J Infect Dis 224, 415\u2013419.","journal-title":"J Infect Dis"},{"key":"2031_CR54","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A.H., Tanaseichuk, O., Benner, C., and Chanda, S.K. (2019). Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10, 1523.","journal-title":"Nat Commun"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-021-2031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-021-2031-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-021-2031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T12:37:43Z","timestamp":1676119063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-021-2031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2031"],"URL":"https:\/\/doi.org\/10.1007\/s11427-021-2031-7","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}